Tuesday, December 20, 2016

BRIEF-Biofrontera: EMA recommends indication expansion of ameluz for treatment of basal cell carcinoma

* European Medicines Agency recommends indication expansion

of ameluz for treatment of basal cell carcinoma

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)